The Operational and Financial Report dated Aug 18, 2014 gives a very good update for where the company is currently and a general time line for the near future. Page one, Recent Operational Highlights, is informative (if you can stomach or skip the biotech verbiage). The last paragraph of page three has a very informative status report from the CEO as well.
see the report at...
DEQI enters mobile poker arena by purchasing the game Actua Poker and will begin distribution of the game to all markets. Management looks top capitalize on exploding demand for mobile gaming apps in the poker niche
NSCT delights the market with news that itsb soon-to-be-released Cloud+MD Office 2.0 is on
track to receive industry M2 certification. News could send valuation pass the $1.50 and reward
It looks like a slow bleed of traders leaving as no news comes out. Remember there was a big private placement that gave this company enough cash to operate for a year or two. That means some big money bought in, and you know they must have done some serious due diligence.
We should be hearing soon that Phase I is complete as they only needed one more person. The company said they will move into Phase II in the second half of 2014. I hope we get a more precise timeline soon. That news should move the stock. They have enough cash to move into and possibly complete Phase II. They should be able to produce enough data to give us a clearer picture of the potential of their drug and delivery system before the cash runs out. At that point, they will look for a license agreement with big pharma or another stock offering. Hopefully, they get a license deal.
Big news about water crisis in Toledo spurs demand for OGNG as volume explodes. Could price levels breach the $1.50 a share mark on this news?
I bought BPTH when it was near 4 many months ago. I think I'm hoping for reassurance I made a good choice even though my investment and the stock price is reduced by 50 %.
Does anyone know why the price is seemingly stagnated and continues to slowly decline? This is my first biotech and its disappointing with no news and the stock slow decline. The up list to the Russell didn't help the stock price. Is there a typical time frame a company such as this endures with a stock price that seems stuck, and what, if any future events would move the price higher?
Thanks in advance.
DPSM launches 3D printing service and gets first orders within 24 hours. Management ramping
up marketing of new service.
Can DPSM break .84 after launch of new products? Company announces launch of Pioneer
Pomade and new dedicated 3D printing service.